Response to Cyclophosphamide-based, seven-drug hybrid and low-dose involved field radiation for the treatment of childhood and adolescent Hodgkin disease

被引：0
|
作者：
Bunin, N [1 ]
Meadows, A [1 ]
Norris, C [1 ]
机构：
[1] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA
来源：
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY | 2001年 / 23卷 / 06期
关键词：
D O I：
10.1097/00043426-200108000-00010
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：369 / 369
页数：1
相关论文
共 34 条
  • [21] Early interim FDG PET/CT prediction of treatment response and prognosis in pediatric Hodgkin disease-added value of low-dose CT
    Ilivitzki, Anat
    Radan, Lea
    Ben-Arush, Miriam
    Israel, Ora
    Ben-Barak, Ayelet
    PEDIATRIC RADIOLOGY, 2013, 43 (01) : 86 - 92
  • [22] Low-dose radiation is sufficient for the noninvolved extended-field treatment in favorable early-stage Hodgkin's disease:: Long-term results of a randomized trial of radiotherapy alone
    Dühmke, E
    Franklin, J
    Pfreundschuh, M
    Sehlen, S
    Willich, N
    Rühl, U
    Müller, RP
    Lukas, P
    Atzinger, A
    Paulus, U
    Lathan, B
    Rüffer, U
    Sieber, M
    Wolf, J
    Engert, A
    Georgii, A
    Staar, S
    Herrmann, R
    Beykirch, M
    Kirchner, H
    Emminger, A
    Greil, R
    Fritsch, E
    Koch, P
    Drochtert, A
    Brosteanu, O
    Hasenclever, D
    Loeffler, M
    Diehl, V
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (11) : 2905 - 2914
  • [23] Impact of low-dose involved-field radiation therapy on pediatric patients with lymphocyte-predominant Hodgkin lymphoma treated with chemotherapy: A report from the Children's Oncology Group
    Appel, Burton E.
    Chen, Lu
    Buxton, Allen
    Wolden, Suzanne L.
    Hodgson, David C.
    Nachman, James B.
    PEDIATRIC BLOOD & CANCER, 2012, 59 (07) : 1284 - 1289
  • [24] Further chemotherapy versus low-dose involved-field radiotherapy as consolidation of complete remission after six cycles of alternating chemotherapy in patients with advanced Hodgkin's disease
    Diehl, V
    Loeffler, M
    Pfreundschuh, M
    Ruehl, U
    Hasenclever, D
    NistersBackes, H
    Sieber, M
    Smith, K
    Tesch, H
    Geilen, W
    Adler, M
    Bartels, H
    Brandenburg, U
    Diezler, P
    Doelken, G
    Enzian, J
    Fuchs, R
    Gassmann, W
    Gerhartz, H
    Hagenaukamp, U
    Hecht, T
    Hiller, E
    Hinkelbein, H
    Lathan, B
    Kirchner, H
    Kuehn, G
    Kuerten, H
    Loos, U
    Makoski, B
    Oertel, W
    Petsch, S
    Pfab, R
    Pflueger, H
    Planker, M
    Rohloff, R
    Sack, H
    Samandari, S
    Sauer, R
    Schalk, K
    Schmitz, G
    Schoppe, W
    Schwieder, G
    Szepesi, S
    Teichmann, J
    Wilhelmy, W
    Worst, P
    Fischer, R
    Georgii, A
    Huebner, K
    Schwarze, EW
    ANNALS OF ONCOLOGY, 1995, 6 (09) : 901 - 910
  • [25] The impact of involved field radiation therapy for patients receiving high-dose chemotherapy followed by hematopoietic progenitor cell transplant for the treatment of relapsed or refractory Hodgkin disease
    Wendland, MMM
    Asch, JD
    Pulsipher, MA
    Thomson, JW
    Shrieve, DC
    Gaffney, DK
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2006, 29 (02): : 189 - 195
  • [26] Localized childhood Hodgkin's disease: Response adapted treatment by chemotherapy (CT) regimen with VP16, bleomycin, vinblastin and prednisone (VBVP) before low-dose radiation therapy (RT). Results of the study by the French society of pediatric oncology (SFOP).
    LandmanParker, J
    Oberlin, O
    Pacquement, H
    Robert, A
    Coze, C
    Thuret, I
    Bertrand, Y
    Nelken, B
    Behar, C
    Schaison, G
    Leverger, G
    Lemerle, J
    BLOOD, 1996, 88 (10) : 352 - 352
  • [27] Low-dose anti-thymocyte globulin plus low-dose post-transplant cyclophosphamide-based regimen for prevention of graft-versus-host disease after haploidentical peripheral blood stem cell transplants: a large sample, long-term follow-up retrospective study
    Li, Xingying
    Yang, Jun
    Cai, Yu
    Huang, Chongmei
    Xu, Xiaowei
    Qiu, Huiying
    Niu, Jiahua
    Zhou, Kun
    Zhang, Ying
    Xia, Xinxin
    Wei, Yu
    Shen, Chang
    Tong, Yin
    Dong, Baoxia
    Wan, Liping
    Song, Xianmin
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [28] Localized childhood Hodgkin's disease: Response-adapted chemotherapy with etoposide, bleomycin, vinblastine, and prednisone before low-dose radiation therapy-results of the French Society of Pediatric Oncology Study MDH90
    Landman-Parker, J
    Pacquement, H
    Leblanc, T
    Habrand, JL
    Terrier-Lacombe, MJ
    Bertrand, Y
    Perel, Y
    Robert, A
    Coze, C
    Thuret, I
    Donadieu, J
    Schaison, G
    Leverger, G
    Lemerle, J
    Oberlin, O
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (07) : 1500 - 1507
  • [29] Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease
    Hudson, MM
    Krasin, M
    Link, MP
    Donaldson, SS
    Billups, C
    Merchant, TE
    Kun, L
    Billet, AL
    Kaste, S
    Tarbell, NJ
    Howard, S
    Friedmann, AM
    Hurwitz, CA
    Young, JA
    Marcus, KC
    Rai, S
    Cowan, T
    Weinstein, HJ
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (22) : 4541 - 4550
  • [30] TREATMENT OF ADVANCED HODGKINS-DISEASE (HD) WITH HIGH-DOSE CYCLOPHOSPHAMIDE (CY) TOTAL-BODY IRRADIATION (TBI) WITH OR WITHOUT INVOLVED-FIELD RADIATION (IFR) AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT)
    WOLFF, SN
    PHILLIPS, GL
    FAY, JW
    LAZARUS, HM
    HERZIG, RH
    HERZIG, GP
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1986, : 253 - 253
1234